Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
暂无分享，去创建一个
J. Thornton | L. Partridge | D. Ivanov | W. Noble | H. M. Cochemé | G. Wells | J. Gatliff | P. Martinez | F. Kerr | H. Bertrand | Helena M. Cochemé | R. Callard | Jennifer Adcott | I. Snoeren | M. Khericha | J. I. Castillo-Quan | Oyinkan Sofola-Adesakin | Beatriz Gomez Perez-Nievas | Jemma Gatliff